Litcius/Paper detail

Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial

Davide Noto, Salvatore Petta, Antonina Giammanco, Rossella Spina, D. Cabibbi, Rossana Porcasi, Rosalia Caldarella, Marcello Ciaccio, R Muratore, Angelo B. Cefalù, Antonio Craxı̀, Maurizio Averna

2022Nutrition Metabolism and Cardiovascular Diseases14 citationsDOI

Topics & Concepts

EzetimibeMedicinePlaceboSteatohepatitisDouble blindInternal medicineWaistPhysical therapyFatty liverAlternative medicineCholesterolObesityDiseasePathologyLiver Disease Diagnosis and TreatmentDrug Transport and Resistance MechanismsDrug-Induced Hepatotoxicity and Protection
Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trial | Litcius